Latest News
FDA SEND 3.1 Mandate Goes Into Effect
Scope of SEND Widens to Include Support for Cardiovascular and Respiratory Studies
CONSHOHOCKEN, PA – March 15, 2019 - - Instem, a leading provider of IT solutions to the global life sciences market, announced today that the next major milestone in the FDA’s adoption of SEND (Standard for Exchange of Nonclinical Data) came into force today.
Instem to Showcase Deep RIM Capabilities at DIA’s Upcoming RSIDM Exhibition
February 7, 2019 - Instem to Present Single-Place-of-Truth™ Approach for Regulatory Affairs Professionals
Instem’s Genetox Software Solution Complements Litron’s State-of-the-Art Genetic Toxicology Testing Methods
February 05, 2019 - Instem Reports that Leading R&D Organizations are Deploying Cyto Study Manager & Cutting-Edge Flow-Cytometric Regulatory Genetox Testing Techniques
Instem Reports Strong Demand for SEND Data Visualization Software in Preclinical Market
January 29, 2019 - Instem is pleased to announce increased demand for its SEND Explorer® software solution.
Instem Reports Increased Market Demand for KnowledgeScan Target Safety Assessment Service
December 17, 2018 - Pioneering Service Delivers Comprehensive Insight into Biological Target Profiling
BTS-UKEMS Annual Congress 2019
April 15 - 17, 2019
Robinson College, Cambridge, UK
STP 38th Annual Meeting
June 22 - 17, 2019
Raleigh Convention Center, Booth #206
Eurotox 2019
September 8 - 11, 2019
Finlandia Hall, Helsinki, Finland